Turnstone Biologics Corp.
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Turnstone Biologics Corp.'s balance sheet done over the years? Its assets were worth $112,815,000 last year, which is less than in the previous period. 13% of Turnstone Biologics Corp.’s total assets is currently financed by debt. Its liabilities reached the amount of $14,148,000, which means an decrease by -93% compared compared to last year.

Debt to Assets

Turnstone Biologics Corp. (NASDAQ:TSBX): Debt to assets
2021 187244000 269.09M 143.71%
2022 114938000 216.40M 188.28%
2023 112815000 14.14M 12.54%

TSBX Balance Sheet (2021 – 2023)

2023 2022 2021
Assets
Current assets:
Cash and cash equivalents
17.79M34.73M123.38M
Short term investments
76.97M47.33M37.63M
Net receivables
194K8.72M6.71M
Inventory
0382K382K
Other current assets
7.58M6.83M9.22M
Total current assets
102.55M98.00M177.34M
Non-current assets:
Property, Plant and Equipment
9.11M14.35M9.36M
Goodwill
000
Intangible assets
000
Long term investments
000
Other non-current assets
1.14M2.58M536K
Total non-current assets
10.26M16.93M9.90M
Total assets
112.81M114.93M187.24M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
015.14M33.02M
Short term debt
4.05M1.96M659K
Total current liabilities
11.97M34.82M54.97M
Non-current liabilities:
Long term debt
1.18M3.20M2.02M
Deferred tax
000
Other non-current liabilities
989K2.26M967K
Total non-current liabilities
2.17M181.57M214.11M
Total liabilities
14.14M216.40M269.09M
Data source